Company
About
Leadership
Management Team
Board of Directors
Scientific Advisors
Corporate Governance
News & Events
Press Releases
Media Coverage
Company Events
Media Resources
Quality Commitment
Careers
Products
Augment
Overview
Mechanism of Action
Role of PDGF in Bone Repair
Scientific Literature
Bone Repair and Formation
Periodontology
Sports Medicine
Data
Augmatrix
Augmatrix Overview
Configuration
Markets
Foot and Ankle Fusion
Spine Fusion
Sports Medicine
Trauma
Investor Relations
Investor Overview
Annual Reports
Corporate Presentations
Investor Events
News Releases
SEC Filings
Proxy Materials
Contact
Contact Us
Request Information
Distributor Information
News Releases
Print Page
|
E-mail this Page
|
E-mail Alerts
Date
Title
01/03/13
BioMimetic Therapeutics, Inc. Initiates Enrollment in Augment™ Chronic Tendinopathy Clinical Trial
11/19/12
Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter into Agreement to Combine Businesses
11/05/12
BioMimetic Therapeutics, Inc. Reports Third Quarter 2012 Financial Results
11/01/12
BioMimetic Therapeutics, Inc. to Report Third Quarter 2012 Financial Results on November 5
08/13/12
BioMimetic Therapeutics, Inc. to Present at the Wedbush PacGrow Life Sciences Management Access Conference
08/02/12
BioMimetic Therapeutics, Inc. Reports Second Quarter 2012 Earnings Results
08/01/12
BioMimetic Therapeutics, Inc. to Report Second Quarter 2012 Financial Results on August 2
07/09/12
BioMimetic Therapeutics Submits Augment® Bone Graft PMA Amendment to FDA
06/21/12
Timothy Daniels, MD Presents Results from Augment™ Injectable Bone Graft Clinical Trial
06/20/12
Presentations from the Regenerative Strategies and Emerging Technologies Forum at the American Orthopedic Foot and Ankle Society Meeting
06/07/12
BioMimetic Therapeutics Announces Highlights from 2012 Annual Meeting of Stockholders
For previous BioMimetic Therapeutics News Releases, please
click here
.